{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:25:07Z","timestamp":1793787907846,"version":"4.6.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015507","name":"Shandong Provincial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jaci.2026.07.001","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:52:37Z","timestamp":1784044357000},"page":"1402-1418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["TNF-\u03b1 is a master regulator of drug-specific T-cell activation"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4520-108X","authenticated-orcid":false,"given":"Joshua","family":"Gardner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonnie","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanood","family":"Howsawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsie","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazi","family":"Dhahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lele","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching Ching","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence A.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Gillgrass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Peckham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jobst F.","family":"Roehmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean J.","family":"Naisbitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.07.001_bib1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI119505","article-title":"Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones","volume":"100","author":"Schnyder","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.07.001_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaci.2017.01.020","article-title":"\u03b2-Lactam hypersensitivity involves expansion of circulating and skin-resident T(H)22 cells","volume":"141","author":"Sullivan","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.001_bib3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jaip.2024.12.003","article-title":"Prospective piperacillin lymphocyte transformation testing in patients with cystic fibrosis receiving regular and desensitization courses of piperacillin-tazobactam","volume":"13","author":"Whitaker","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.07.001_bib4","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B\u22175801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2026.07.001_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A\u221732:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.001_bib6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of HLA-B\u22175701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.07.001_bib7","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa1213096","article-title":"HLA-B\u221713:01 and the dapsone hypersensitivity syndrome","volume":"369","author":"Zhang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.07.001_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaci.2026.07.001_bib9","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.1038\/s41467-024-52990-3","article-title":"Multiomic single-cell sequencing defines tissue-specific responses in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"15","author":"Gibson","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.07.001_bib10","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1038\/s41467-019-11396-2","article-title":"Identification of drug-specific public TCR driving severe cutaneous adverse reactions","volume":"10","author":"Pan","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.07.001_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe0013","article-title":"Massive clonal expansion of polycytotoxic skin and blood CD8(+) T cells in patients with toxic epidermal necrolysis","volume":"7","author":"Villani","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.jaci.2026.07.001_bib12","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI3544","article-title":"HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes","volume":"102","author":"Zanni","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.07.001_bib13","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.4049\/jimmunol.164.12.6647","article-title":"Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals","volume":"164","author":"Schnyder","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.07.001_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2009.10.031","article-title":"Stimulation of human T cells with sulfonamides and sulfonamide metabolites","volume":"125","author":"Castrejon","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.001_bib15","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/all.13418","article-title":"Identification of T-cell epitopes from benzylpenicillin conjugated to human serum albumin and implication in penicillin allergy","volume":"73","author":"Azoury","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.001_bib16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.26077","article-title":"Human leukocyte antigen (HLA)-B\u221757:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury","volume":"57","author":"Monshi","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jaci.2026.07.001_bib17","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/toxsci\/kfaa124","article-title":"Identification of flucloxacillin-haptenated HLA-B\u221757:01 ligands: evidence of antigen processing and presentation","volume":"177","author":"Waddington","year":"2020","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jaci.2026.07.001_bib18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/toxsci\/kfs080","article-title":"The development of in vitro culture methods to characterize primary T-cell responses to drugs","volume":"127","author":"Faulkner","year":"2012","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jaci.2026.07.001_bib19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jaci.2016.11.032","article-title":"Identification of drug- and drug-metabolite immune responses originating from both naive and memory T cells","volume":"140","author":"Gibson","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.001_bib20","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.4049\/jimmunol.1302720","article-title":"Negative regulation by PD-L1 during drug-specific priming of IL-22-secreting T cells and the influence of PD-1 on effector T cell function","volume":"192","author":"Gibson","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.07.001_bib21","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1398-9995.2004.00547.x","article-title":"The lymphocyte transformation test in the diagnosis of drug hypersensitivity","volume":"59","author":"Pichler","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.001_bib22","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1207934109","article-title":"Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire","volume":"109","author":"Ostrov","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2026.07.001_bib23","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.07.001_bib24","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1097\/QAD.0b013e328355fe8f","article-title":"Abacavir induces loading of novel self-peptides into HLA-B\u221757:01: an autoimmune model for HLA-associated drug hypersensitivity","volume":"26","author":"Norcross","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.jaci.2026.07.001_bib25","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","article-title":"Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity","volume":"28","author":"Chessman","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.07.001_bib26","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B\u22175701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.07.001_bib27","doi-asserted-by":"crossref","first-page":"46ra62","DOI":"10.1126\/scitranslmed.3001116","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response","volume":"2","author":"Picard","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2026.07.001_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaci.2015.05.050","article-title":"Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response","volume":"136","author":"White","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.001_bib29","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/all.16393","article-title":"Feedback regulation of VISTA and Treg by TNF-\u03b1 controls T cell responses in drug allergy","volume":"80","author":"Sun","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.001_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/gm350","article-title":"In silico analysis of HLA associations with drug-induced liver injury: use of a HLA-genotyped DNA archive from healthy volunteers","volume":"4","author":"Alfirevic","year":"2012","journal-title":"Genome Med"},{"key":"10.1016\/j.jaci.2026.07.001_bib31","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/toxsci\/kfw177","article-title":"Detection of primary T cell responses to drugs and chemicals in HLA-typed volunteers: implications for the prediction of drug immunogenicity","volume":"154","author":"Faulkner","year":"2016","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jaci.2026.07.001_bib32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4049\/jimmunol.1100647","article-title":"Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis","volume":"187","author":"Whitaker","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.07.001_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.bjp.0704074","article-title":"Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo","volume":"133","author":"Naisbitt","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaci.2026.07.001_bib34","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/all.13769","article-title":"Dapsone- and nitroso dapsone-specific activation of T cells from hypersensitive patients expressing the risk allele HLA-B\u221713:01","volume":"74","author":"Zhao","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.001_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/toxsci\/kfab084","article-title":"Deciphering adverse drug reactions: in vitro priming and characterization of vancomycin-specific T-cells from healthy donors expressing HLA-A\u221732:01","volume":"183","author":"Ogese","year":"2021","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jaci.2026.07.001_bib36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/toxsci\/kfaf074","article-title":"Elucidating CD4+ and CD8+ T-cell involvement in patients with vancomycin-induced DRESS","volume":"206","author":"Gardner","year":"2025","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jaci.2026.07.001_bib37","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","article-title":"TNF alpha and the TNF receptor superfamily: structure-function relationship(s)","volume":"50","author":"Idriss","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.jaci.2026.07.001_bib38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri3834","article-title":"Regulation of tumour necrosis factor signalling: live or let die","volume":"15","author":"Brenner","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.07.001_bib39","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2024.2422924","article-title":"TNF-\u03b1 inhibitors as therapy for drug-induced severe cutaneous adverse reactions: a case series","volume":"35","author":"Chu","year":"2024","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaci.2026.07.001_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222010922","article-title":"Cytokine networks in the pathogenesis of rheumatoid arthritis","volume":"22","author":"Kondo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2026.07.001_bib41","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.3748\/wjg.v29.i18.2733","article-title":"Study of tumor necrosis factor receptor in the inflammatory bowel disease","volume":"29","author":"Souza","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaci.2026.07.001_bib42","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1172\/JCI93349","article-title":"Randomized, controlled trial of TNF-\u03b1 antagonist in CTL-mediated severe cutaneous adverse reactions","volume":"128","author":"Wang","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.07.001_bib43","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/diagnostics10110918","article-title":"Prevalence and impact of reported drug allergies among rheumatology patients","volume":"10","author":"Chan","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jaci.2026.07.001_bib44","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jid.2022.11.024","article-title":"TNF-\u03b1\u2012mediated keratinocyte expression and release of matrix metalloproteinase 9: putative mechanism of pathogenesis in Stevens\u2012Johnson syndrome\/toxic epidermal necrolysis","volume":"143","author":"Olsson-Brown","year":"2023","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2026.07.001_bib45","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/1346-8138.16847","article-title":"TNF-\u03b1 induced extracellular release of keratinocyte high-mobility group box 1 in Stevens-Johnson syndrome\/toxic epidermal necrolysis: biomarker and putative mechanism of pathogenesis","volume":"50","author":"Nwikue","year":"2023","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2026.07.001_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay0524","article-title":"VISTA is a checkpoint regulator for na\u00efve T cell quiescence and peripheral tolerance","volume":"367","author":"ElTanbouly","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jaci.2026.07.001_bib47","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1124\/jpet.111.190900","article-title":"Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis","volume":"341","author":"El-Ghaiesh","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaci.2026.07.001_bib48","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/tx400124m","article-title":"\u03b2-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis","volume":"26","author":"Jenkins","year":"2013","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jaci.2026.07.001_bib49","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.4049\/jimmunol.1700209","article-title":"Definition of the nature and hapten threshold of the \u03b2-lactam antigen required for t cell activation in vitro and in patients","volume":"198","author":"Meng","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.07.001_bib50","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.alit.2025.09.004","article-title":"The Cyto-LTT: a multiplex cytokine assay to detect and assess the strength of T cell reactivity in drug hypersensitivity","volume":"75","author":"Peyer","year":"2026","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2026.07.001_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2026.01.010","article-title":"Current drug hypersensitivity challenges facing patients with cystic fibrosis","author":"Gardner","year":"2026","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jaci.2026.07.001_bib52","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.3390\/ijms22041952","article-title":"Dysfunctional inflammation in cystic fibrosis airways: from mechanisms to novel therapeutic approaches","volume":"22","author":"Ghigo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2026.07.001_bib53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jcf.2004.06.006","article-title":"Cytokines and inflammatory mediators in cystic fibrosis","volume":"3","author":"Courtney","year":"2004","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jaci.2026.07.001_bib54","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.54556","article-title":"Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis","volume":"9","author":"Jarosz-Griffiths","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jaci.2026.07.001_bib55","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jcf.2016.05.016","article-title":"Airway inflammation in mild cystic fibrosis","volume":"16","author":"Eckrich","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jaci.2026.07.001_bib56","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/thx.46.2.91","article-title":"Plasma tumour necrosis factor alpha in cystic fibrosis","volume":"46","author":"Norman","year":"1991","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2026.07.001_bib57","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2125.2010.03764.x","article-title":"Delayed drug hypersensitivity: models of T-cell stimulation","volume":"71","author":"Adam","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2026.07.001_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-69054-7","article-title":"Viral reactivation and clinical outcomes in drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"14","author":"Chan","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2026.07.001_bib59","article-title":"HLA-B\u221758:01 is an incomplete predictor of allopurinol-induced severe cutaneous adverse reactions","author":"Campbell","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.jaci.2026.07.001_bib60","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/clpt.2012.189","article-title":"HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review","volume":"92","author":"Yip","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaci.2026.07.001_bib61","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jaci.2025.11.005","article-title":"Nonsteroidal anti-inflammatory drug-induced acute urticaria\/angioedema associated with atopy-related genes\u2019 genetic variants","volume":"157","author":"Jim\u00e9nez-S\u00e1nchez","year":"2026","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.001_bib62","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1074\/jbc.M110676200","article-title":"Nonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAPK induction","volume":"277","author":"Paccani","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2026.07.001_bib63","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-med-050913-022745","article-title":"T cell-mediated hypersensitivity reactions to drugs","volume":"66","author":"Pavlos","year":"2015","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jaci.2026.07.001_bib64","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.smim.2004.08.014","article-title":"CD8 memory T cells: cross-reactivity and heterologous immunity","volume":"16","author":"Selin","year":"2004","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaci.2026.07.001_bib65","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6431694","article-title":"An updated review of the molecular mechanisms in drug hypersensitivity","volume":"2018","author":"Chen","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaci.2026.07.001_bib66","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3390\/ijms22042147","article-title":"Current perspective regarding the immunopathogenesis of drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS)","volume":"22","author":"Miyagawa","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2026.07.001_bib67","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/ACI.0000000000001083","article-title":"The role of regulatory T cells in preventing the development of drug hypersensitivity reactions","volume":"25","author":"MacDonald","year":"2025","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.001_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1107437","article-title":"Regulatory T cell enhancement in adults with cystic fibrosis receiving elexacaftor\/tezacaftor\/ivacaftor therapy","volume":"14","author":"Westh\u00f6lter","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.07.001_bib69","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00130832-200208000-00003","article-title":"Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept","volume":"2","author":"Pichler","year":"2002","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.001_bib70","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1124\/mol.62.3.628","article-title":"Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation","volume":"62","author":"Naisbitt","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jaci.2026.07.001_bib71","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1021\/acs.chemrestox.7b00263","article-title":"Dapsone and nitroso dapsone activation of naive T-cells from healthy donors","volume":"30","author":"Alzahrani","year":"2017","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jaci.2026.07.001_bib72","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/09546634.2019.1577548","article-title":"Biologic TNF-alpha inhibitors in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a systemic review","volume":"31","author":"Zhang","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaci.2026.07.001_bib73","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s13555-023-00928-w","article-title":"Biologic TNF-\u03b1 inhibitors for Stevens-Johnson syndrome, toxic epidermal necrolysis, and TEN-SJS overlap: a study-level and patient-level meta-analysis","volume":"13","author":"Cao","year":"2023","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926004859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926004859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:31:40Z","timestamp":1793784700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926004859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0091674926004859"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.07.001","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNF-\u03b1 is a master regulator of drug-specific T-cell activation","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}